These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30922102)

  • 21. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
    Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits.
    Lenk HÇ; Løvsletten Smith R; O'Connell KS; Jukić MM; Kringen MK; Andreassen OA; Ingelman-Sundberg M; Molden E
    Clin Transl Sci; 2023 Jan; 16(1):62-72. PubMed ID: 36152308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis.
    Ortega-Vázquez A; Mayen-Lobo YG; Dávila-Ortiz de Montellano DJ; Tristán-López L; Aviña-Cervantes CL; Ríos C; López-López M; Monroy-Jaramillo N
    Drug Dev Res; 2021 Aug; 82(5):685-694. PubMed ID: 33336447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoking, coffee consumption, alcohol intake, and clozapine metabolism: A Mendelian randomization study.
    Zeng L; Lv H; Li J; Xue R; Liu X; Zhou C; Yu H
    Front Psychiatry; 2022; 13():1002235. PubMed ID: 36245885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin strongly inhibits clozapine metabolism: two case reports.
    Brouwers EE; Söhne M; Kuipers S; van Gorp EC; Schellens JH; Koks CH; Beijnen JH; Huitema AD
    Clin Drug Investig; 2009; 29(1):59-63. PubMed ID: 19067475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine: more than 900 mg/day may be needed.
    Maccall C; Billcliff N; Igbrude W; Natynczuk S; Spencer EP; Flanagan RJ
    J Psychopharmacol; 2009 Mar; 23(2):206-10. PubMed ID: 18515467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
    Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
    Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study.
    Chen J; Yang P; Zhang Q; Chen R; Wang P; Liu B; Sun W; Jian X; Xiang S; Zhou J; Li N; Wang K; Gao C; Wen Y; Wu C; Zhang J; Zhao Y; Yang Q; Li M; Stewart R; Sun Y; Pan D; Niu Y; Wang Z; Xu Y; Li X; He L; Li Z; Shi Y
    Transl Psychiatry; 2021 Jun; 11(1):343. PubMed ID: 34083506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
    Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
    J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia.
    Willcocks IR; Legge SE; Nalmpanti M; Mazzeo L; King A; Jansen J; Helthuis M; Owen MJ; O'Donovan MC; Walters JTR; Pardiñas AF
    Front Pharmacol; 2021; 12():658734. PubMed ID: 33959025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of genome-wide association studies of antipsychotic response.
    Allen JD; Bishop JR
    Pharmacogenomics; 2019 Mar; 20(4):291-306. PubMed ID: 30883267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism.
    Reznik R; Chen RYY; Stanford P
    Australas Psychiatry; 2018 Dec; 26(6):608-611. PubMed ID: 29737183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
    Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
    Sriretnakumar V; Huang E; Müller DJ
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
    Zhang C; Zhang Y; Cai J; Chen M; Song L
    Pharmacogenomics J; 2017 Jan; 17(1):92-97. PubMed ID: 26503818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure.
    Söderberg MM; Haslemo T; Molden E; Dahl ML
    Pharmacogenet Genomics; 2013 May; 23(5):279-85. PubMed ID: 23492908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting interindividual differences in clozapine response: a review and case report.
    Bersani FS; Capra E; Minichino A; Pannese R; Girardi N; Marini I; Delle Chiaie R; Biondi M
    Hum Psychopharmacol; 2011 Apr; 26(3):177-87. PubMed ID: 21455971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.